COVID-HEP Registry
COVID-HEP Registry is a universal and collaborative registry project to collect data on patients with liver disease at any stage or liver transplants who develop laboratory-confirmed COVID-19. We are pleased to encourage reports from worldwide. However, if reporting from the Americas or China/Japan/Korea, please see our collaborators at: SECURE-cirrhosis.
Description
More detailed information about this field from each metasource.
COVID-HEP Registry is a universal and collaborative registry project to collect data on patients with liver disease at any stage or liver transplants who develop laboratory-confirmed COVID-19. We are pleased to encourage reports from worldwide. However, if reporting from the Americas or China/Japan/Korea, please see our collaborators at: SECURE-cirrhosis.
metasource: Fairsharing.orgversion: FAIRsharing.org: COVID-HEP Registry; COVID-HEP Registry; DOI: https://doi.org/10.25504/FAIRsharing.bsAeqi; Last edited: May 20, 2021, 1:41 p.m.; Last accessed: Jan 03 2022 7:07 p.m.
Webpage:
https://www.covid-hep.net/Webpage
More detailed information about this field from each metasource.
https://www.covid-hep.net/
metasource: Fairsharing.orgversion: FAIRsharing.org: COVID-HEP Registry; COVID-HEP Registry; DOI: https://doi.org/10.25504/FAIRsharing.bsAeqi; Last edited: May 20, 2021, 1:41 p.m.; Last accessed: Jan 03 2022 7:07 p.m.
Publications:
Publications
More detailed information about this field from each metasource.
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
PMID: 33035628
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-HEP Registry; COVID-HEP Registry; DOI: https://doi.org/10.25504/FAIRsharing.bsAeqi; Last edited: May 20, 2021, 1:41 p.m.; Last accessed: Jan 03 2022 7:07 p.m.
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
PMID: 32866433
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-HEP Registry; COVID-HEP Registry; DOI: https://doi.org/10.25504/FAIRsharing.bsAeqi; Last edited: May 20, 2021, 1:41 p.m.; Last accessed: Jan 03 2022 7:07 p.m.
Publications
More detailed information about this field from each metasource.
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
PMID: 33035628
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-HEP Registry; COVID-HEP Registry; DOI: https://doi.org/10.25504/FAIRsharing.bsAeqi; Last edited: May 20, 2021, 1:41 p.m.; Last accessed: Jan 03 2022 7:07 p.m.
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
PMID: 32866433
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-HEP Registry; COVID-HEP Registry; DOI: https://doi.org/10.25504/FAIRsharing.bsAeqi; Last edited: May 20, 2021, 1:41 p.m.; Last accessed: Jan 03 2022 7:07 p.m.
-
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
PubMed citations: 140.
140 articles citing: Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
Predictors of clinical outcomes of hospitalized patients with Covid-19: focusing on pre-existing liver disease. PMID:35904701
The Association of Metabolic-Associated Fatty Liver Disease with Clinical Outcomes of COVID-19: A Systematic Review and Meta-Analysis. PMID:35899064
COVID-19 and liver diseases. PMID:35880136
Liver transplant after SARS-CoV-2 infection: A systematic review. PMID:35870265
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper. PMID:35868584
Breakthrough SARS-CoV-2 Infection Outcomes in Vaccinated Patients with Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study. PMID:35821984
Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update. PMID:35814781
Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China. PMID:35786362
Are nucleos(t)ide analogues effective against severe outcomes in COVID-19 and hepatitis B virus coinfection? PMID:35784904
SARS-CoV-2 infection and liver involvement. PMID:35767172
Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis. PMID:35750943
Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest. PMID:35718592
Pediatric transplantation during the COVID-19 pandemic. PMID:35663540
Ongoing Clinical Trials in Aging-Related Tissue Fibrosis and New Findings Related to AhR Pathways. PMID:35656117
COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status. PMID:35578350
Optimizing Immunization Strategies in Adult Patients With Chronic Liver Disease and Liver Transplant Recipients. PMID:35505940
COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry. PMID:35482663
Impact of COVID-19 on the Gastrointestinal Tract: A Clinical Review. PMID:35464519
Effects of SARS-CoV-2 Inflammation on Selected Organ Systems of the Human Body. PMID:35456997
COVID-19 and liver cancer: lost patients and larger tumours. PMID:35450934
Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patients. PMID:35412018
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury. PMID:35410851
Clinical Practice Issues for Liver Transplantation in COVID-19 Recovered Recipients. PMID:35410523
Infection of liver hepatocytes with SARS-CoV-2. PMID:35347317
Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers. PMID:35335009
SARS-CoV-2 infection: a hurricane that does not ignore chronic hepatitis. PMID:35316530
COVID-19 and liver disease: where are we now? PMID:35301465
Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases. PMID:35215801
COVID-19: Gastrointestinal manifestations, liver injury and recommendations. PMID:35211548
Involvement of the Liver in COVID-19: A Systematic Review. PMID:35203056
Seroprevalence of hepatitis B and C viruses in moderate and severe COVID-19 inpatients: A cross-sectional study at a referral center in Mexico. PMID:35167956
Predictors of Severity and Mortality in Chronic Liver Disease Patients With COVID-19 During the Second Wave of the Pandemic in India. PMID:35145796
Vaccination against COVID-19 decreases hospitalizations in patients with cirrhosis: Results from a nationwide analysis. PMID:35129285
Metabolic and nutritional triggers associated with increased risk of liver complications in SARS-CoV-2. PMID:35126841
Covid-19 pandemic in Egyptian children with liver diseases: Incidence and impact on health care service delivery in a low/middle income country. PMID:35120837
Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review. PMID:35115233
Clinical Effect of Hepatitis B Virus on COVID-19 Infected Patients: A Nationwide Population-Based Study Using the Health Insurance Review & Assessment Service Database. PMID:35075828
COVID-19 and the liver: A brief and core review. PMID:35070005
Response to M. Amin: COVID-19 and the liver: overview. PMID:35048668
Vaccination in Chronic Liver Disease: An Update. PMID:34975241
Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases. PMID:34968728
Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients. PMID:34966658
Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic. PMID:34941875
Predictors of Mortality Among Hospitalized COVID-19 Patients at a Tertiary Care Hospital in Ethiopia. PMID:34938084
Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. PMID:34909404
Clinical Features of Early Stage COVID-19 in a Primary Care Setting. PMID:34888326
Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study. PMID:34876795
The Outcome in Cirrhosis after Hospital Discharge is Not Worsened with COVID-19 Infection: A Propensity Score-matched Analysis. PMID:34840484
Baseline factors associated with death in a COVID-19 hospital cohort, Sao Paulo, 2020. PMID:34816979
Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review. PMID:34816011
Liver and COVID-19: From care of patients with liver diseases to liver injury. PMID:34786172
Liver Injury in Patients with Coronavirus Disease 2019 (COVID-19)-A Narrative Review. PMID:34768568
Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases. PMID:34760721
The Impact of COVID-19 on Liver Injury. PMID:34752738
Predictors of in-hospital Outcomes in Patients With Cirrhosis and Coronavirus Disease-2019. PMID:34728983
SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination. PMID:34708575
Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studies. PMID:34675033
Covid-19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis. PMID:34658172
Liver disease in the era of COVID-19: Is the worst yet to come? PMID:34629818
Liver-spleen axis dysfunction in COVID-19. PMID:34629809
Impact of COVID-19 on liver. PMID:34621856
Reshape and secure HCC managing during COVID-19 pandemic: A single centre analysis of four periods in 2020 versus 2019. PMID:34614270
Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients. PMID:34575333
Seroconversion After Coronavirus Disease 2019 Vaccination in Patients Awaiting Liver Transplantation: Fact or Fancy? PMID:34564945
Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence. PMID:34552698
Impact of COVID-19 in Liver Disease Progression. PMID:34533001
Alcohol-Associated Liver Disease Before and After COVID-19-An Overview and Call for Ongoing Investigation. PMID:34510833
SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients. PMID:34509643
Hepatitis B and C screening in hospitalized patients with SARS-CoV-2 infection. PMID:34508809
Increased Hepatic Expression of SARS-CoV-2 Entry Points and Proinflammatory Cytokines in Cirrhosis. PMID:34481957
Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases. PMID:34454993
COVID-19 and Cirrhosis: A Combination We Must Strive to Prevent. PMID:34453892
Liver Transplantation Services During the Time of COVID-19. PMID:34447689
Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care. PMID:34447688
Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review. PMID:34447687
Long COVID-19 Syndrome: A Comprehensive Review of Its Effect on Various Organ Systems and Recommendation on Rehabilitation Plans. PMID:34440170
COVID-19 and Effect on Liver Transplant. PMID:34421290
Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database. PMID:34406805
Reply. PMID:34392551
Letter to the Editor: Outcomes in chronic hepatitis B infection and COVID-19-Not always benign! PMID:34387897
Letter to the Editor: Unanswered questions about hepatitis B virus infection in patients with COVID-19. PMID:34387876
Gastrointestinal symptoms and healthcare utilization have increased among patients with functional gastrointestinal and motility disorders during the COVID-19 pandemic. PMID:34378840
COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later. PMID:34352133
Elevations in Liver Transaminases in COVID-19: (How) Are They Related? PMID:34336904
Liver dysfunction and SARS-CoV-2 infection. PMID:34326607
Identifying Patients at Highest Risk of Remaining Unvaccinated Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Large Veterans Health Administration Cohort. PMID:34293247
Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study. PMID:34284037
COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study. PMID:34281984
Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis. PMID:34278287
Association of BNT162b2 mRNA and mRNA-1273 Vaccines With COVID-19 Infection and Hospitalization Among Patients With Cirrhosis. PMID:34254978
Reply to: "COVID-19-associated liver injury (COVALI): role of hepatologists". PMID:34251568
COVID-19 and its effects on the digestive system. PMID:34239265
COVID-19-associated liver injury (COVALI): role of hepatologists. PMID:34212231
COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology. PMID:34190413
COVID-19 Vaccines in Patients With Chronic Liver Disease. PMID:34177192
COVID-19 and the liver - Lessons learned. PMID:34155789
Reply. PMID:34147681
COVID-19 impact on the liver. PMID:34141738
COVID-19 and the liver: What do we know so far? PMID:34131467
Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study. PMID:34127981
Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey. PMID:34105883
Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation. PMID:34100388
Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic. PMID:34096188
Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients. PMID:34079691
Liver Injury in Severe COVID-19 Disease: Need a Closer Look! PMID:34029750
Effects of the COVID-19 pandemic and lockdown on alcohol use disorders and complications. PMID:34016817
Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease. PMID:34007808
Coronavirus Disease-2019 (COVID-19) and the Liver. PMID:34007807
Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis. PMID:33997748
Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation. PMID:33994708
Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives. PMID:33969082
Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. PMID:33958841
Italian association for the study of the liver position statement on SARS-CoV2 vaccination. PMID:33941488
Gastroenterology 2021: from the heart of the COVID-19 pandemic. PMID:33907619
Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection. PMID:33864948
Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity. PMID:33859644
Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain. PMID:33802486
Liver transplantation for acute liver failure in a SARS-CoV-2 PCR-positive patient. PMID:33792185
COVID-19 in Children With Liver Disease. PMID:33777864
Interaction between hepatitis B virus and SARS-CoV-2 infections. PMID:33727770
SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic Implications. PMID:33693046
COVID-19 and liver disease: mechanistic and clinical perspectives. PMID:33692570
COVID-19 in a Patient with Liver Cirrhosis. PMID:33686051
Assessing the impact of COVID-19 on liver cancer management (CERO-19). PMID:33644725
Liver injury in the era of COVID-19. PMID:33584070
EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients. PMID:33563499
Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients. PMID:33556419
COVID-19 in hospitalized liver transplant recipients: An early systematic review and meta-analysis. PMID:33555058
Implications of COVID-19 for patients with pre-existing digestive diseases: an update. PMID:33539813
SARS-CoV-2 infection in patients with autoimmune hepatitis. PMID:33508378
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study. PMID:33492523
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question. PMID:33444545
The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection. PMID:33402334
Severe Acute Respiratory Syndrome Coronavirus 2-related Acute-on-chronic Liver Failure. PMID:33398222
Association of liver abnormalities with in-hospital mortality in patients with COVID-19. PMID:33347952
Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial. PMID:33247380
Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities With Chronic Liver Diseases. PMID:33227281
COVID-19 and liver transplantation: the jury is still out - Authors' reply. PMID:33137285
SARS-CoV-2 in patients with chronic liver disease. PMID:33128018
COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist. PMID:33040064 -
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
PubMed citations: 103.
103 articles citing: Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper. PMID:35868584
Incidence and Impact of COVID-19 Cases in Brazilian Liver Transplant Recipients: An Academic, Single-center Experience. PMID:35787311
SARS-CoV-2 infection and liver involvement. PMID:35767172
COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus. PMID:35636907
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis. PMID:35631084
Collateral Effects and Mortality of Kidney Transplant Recipients during the COVID-19 Pandemic. PMID:35373117
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study. PMID:35318432
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis. PMID:35289294
A retrospective analysis of 902 hospitalized COVID-19 patients in Lebanon: clinical epidemiology and risk factors. PMID:35262028
Clinical characteristics and outcome of coronavirus disease 2019 infection in patients with solid organ transplants: A systematic review and meta-analysis. PMID:35193818
Coronavirus Precautions: Experience of High Volume Liver Transplant Institute. PMID:35115295
Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review. PMID:35115233
Vaccination in Chronic Liver Disease: An Update. PMID:34975241
Humoral Immune Response following SARS-CoV-2 Vaccination in Liver Transplant Recipients. PMID:34960168
Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. PMID:34909404
SARS-CoV-2 infection in liver transplant recipients: A complex relationship. PMID:34908810
Immunosuppressants in Liver Transplant Recipients With Coronavirus Disease 2019: Capability or Catastrophe?-A Systematic Review and Meta-Analysis. PMID:34859012
CON: Liver Transplantation in the Times of COVID-19: Patients with COVID-19 Infection Should not Undergo Liver Transplantation. PMID:34840724
COVID-19 Vaccine Acceptance among Liver Transplant Recipients. PMID:34835245
Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study. PMID:34814851
Liver and COVID-19: From care of patients with liver diseases to liver injury. PMID:34786172
Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects. PMID:34786167
Coronavirus Disease 2019 Vaccination Is Associated With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Death in Liver Transplant Recipients. PMID:34758352
SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination. PMID:34708575
The Impact of Severe Acute Respiratory Syndrome Coronavirus Type 2 on Children With Liver Diseases: A Joint European Society for Pediatric Gastroenterology, Hepatology and Nutrition and Society of Pediatric Liver Transplantation Position Paper. PMID:34694269
National survey on deceased donor organ transplantation during the COVID-19 pandemic in Japan. PMID:34686930
Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studies. PMID:34675033
Potential Effects of Coronaviruses on the Liver: An Update. PMID:34646834
Liver-spleen axis dysfunction in COVID-19. PMID:34629809
Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19? PMID:34552938
SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020. PMID:34551880
Impact of COVID-19 in Liver Disease Progression. PMID:34533001
Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline. PMID:34530524
PRO: Liver Transplantation in the Times of COVID-19: Patients with COVID-19 Infection Should Undergo Liver Transplantation. PMID:34518778
SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients. PMID:34509643
COVID-19 in Liver Transplant Recipients: A Systematic Review. PMID:34501463
A pragmatic outreach pilot to understand and overcome barriers to COVID-19 vaccination in abdominal organ transplant. PMID:34496115
Successful Liver Transplantation in a Patient With Acute COVID-19 Infection and Acute Liver Failure: A Case Report. PMID:34476292
Recent challenges facing patients with preexisting chronic liver disease in the era of the COVID-19 pandemic. PMID:34475732
Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases. PMID:34454993
Liver transplantation during global COVID-19 pandemic. PMID:34447809
Liver Transplantation Services During the Time of COVID-19. PMID:34447689
COVID-19 in Liver Transplant Recipients. PMID:34447684
COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. PMID:34434987
COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms. PMID:34428501
COVID-19 and Effect on Liver Transplant. PMID:34421290
Pediatric liver transplantation activity in a high-volume program during the COVID-19 pandemic in Brazil. PMID:34396644
Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management. PMID:34366621
COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later. PMID:34352133
Liver dysfunction and SARS-CoV-2 infection. PMID:34326607
Immunosuppression in solid organ transplant recipients with Covid-19: More data, but still complicated. PMID:34325492
"SARS-CoV-2 Infection in Liver Transplant Recipients - Immunosuppression is the Silver Lining?". PMID:34305351
Impact of COVID-19 on liver transplant recipients-A systematic review and meta-analysis. PMID:34278287
Clinical Characteristics and Outcomes of Liver Transplantation Recipients With COVID-19 Pneumonia. PMID:34261580
COVID-19 in Solid Organ Transplant Recipients: a Review of the Current Literature. PMID:34220357
COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology. PMID:34188251
Liver injury in COVID-19: Detection, pathogenesis, and treatment. PMID:34168405
COVID-19 and the liver - Lessons learned. PMID:34155789
Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort. PMID:34121244
COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. PMID:34117116
A Case of COVID-19 Re-Infection in a Liver Transplant Patient. PMID:34113522
In Silico Evaluation of Cyclophilin Inhibitors as Potential Treatment for SARS-CoV-2. PMID:34109257
Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey. PMID:34105883
Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic. PMID:34096188
COVID-19 in normal, diseased and transplanted liver. PMID:34092976
COVID-19 and Short- and Medium-term Outcomes in Liver Transplant Patients: A Spanish Single-center Case Series. PMID:34092967
Immunosuppression practices during the COVID-19 pandemic: A multinational survey study of transplant programs. PMID:34050961
COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study. PMID:34008917
Coronavirus Disease-2019 (COVID-19) and the Liver. PMID:34007807
Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation. PMID:33994708
Outcomes of COVID-19 in solid organ transplant recipients: A matched cohort study. PMID:33993630
Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020. PMID:33992699
Outcomes of COVID-19 in Solid Organ Transplant Recipients: A Propensity-matched Analysis of a Large Research Network. PMID:33988341
Italian association for the study of the liver position statement on SARS-CoV2 vaccination. PMID:33941488
Impact of COVID-19 on the outcomes of gastrointestinal surgery. PMID:33928515
Gastroenterology 2021: from the heart of the COVID-19 pandemic. PMID:33907619
Reply to: "Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients". PMID:33862040
Impact of the COVID-19 pandemic on liver donation and transplantation: A review of the literature. PMID:33776364
SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic Implications. PMID:33693046
COVID-19 and liver disease: mechanistic and clinical perspectives. PMID:33692570
COVID-19 in a Patient with Liver Cirrhosis. PMID:33686051
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor. PMID:33621393
Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Children With Liver Transplant and Native Liver Disease: An International Observational Registry Study. PMID:33605666
Keeping the lights on: Telehealth, testing, and 6-month outcomes for orthotopic liver transplantation during the COVID-19 pandemic. PMID:33589248
American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease. PMID:33577086
Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients. PMID:33556419
COVID-19 in hospitalized liver transplant recipients: An early systematic review and meta-analysis. PMID:33555058
Implications of COVID-19 for patients with pre-existing digestive diseases: an update. PMID:33539813
SARS-CoV-2 infection in patients with autoimmune hepatitis. PMID:33508378
SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study. PMID:33451759
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question. PMID:33444545
COVID-19 Among Liver Transplant Recipients. PMID:33417941
Tacrolimus: Unlikely Harmful and Perhaps Helpful in Liver Transplant Recipients with COVID-19. PMID:33387518
COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature. PMID:33246166
COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. PMID:33139693
COVID-19 and liver transplantation: the jury is still out. PMID:33137286
COVID-19 and liver transplantation: the jury is still out - Authors' reply. PMID:33137285
Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients. PMID:33127455
Reply to Hage and Schuurmans. PMID:33104183
COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist. PMID:33040064
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study. PMID:33035628
Unexpected better outcome in a liver transplant recipient with COVID-19: a beneficial effect of tacrolimus? PMID:33032841
SARS-CoV-2 infection in liver transplant recipients: collaboration in the time of COVID-19. PMID:32956620
Tags:
Tags
More detailed information about this field from each metasource.
liver disease
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-HEP Registry; COVID-HEP Registry; DOI: https://doi.org/10.25504/FAIRsharing.bsAeqi; Last edited: May 20, 2021, 1:41 p.m.; Last accessed: Jan 03 2022 7:07 p.m.
patient care
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-HEP Registry; COVID-HEP Registry; DOI: https://doi.org/10.25504/FAIRsharing.bsAeqi; Last edited: May 20, 2021, 1:41 p.m.; Last accessed: Jan 03 2022 7:07 p.m.
report
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-HEP Registry; COVID-HEP Registry; DOI: https://doi.org/10.25504/FAIRsharing.bsAeqi; Last edited: May 20, 2021, 1:41 p.m.; Last accessed: Jan 03 2022 7:07 p.m.
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-HEP Registry; COVID-HEP Registry; DOI: https://doi.org/10.25504/FAIRsharing.bsAeqi; Last edited: May 20, 2021, 1:41 p.m.; Last accessed: Jan 03 2022 7:07 p.m.
Tags
More detailed information about this field from each metasource.
liver disease
metasource: Fairsharing.orgversion: FAIRsharing.org: COVID-HEP Registry; COVID-HEP Registry; DOI: https://doi.org/10.25504/FAIRsharing.bsAeqi; Last edited: May 20, 2021, 1:41 p.m.; Last accessed: Jan 03 2022 7:07 p.m.
patient care
metasource: Fairsharing.orgversion: FAIRsharing.org: COVID-HEP Registry; COVID-HEP Registry; DOI: https://doi.org/10.25504/FAIRsharing.bsAeqi; Last edited: May 20, 2021, 1:41 p.m.; Last accessed: Jan 03 2022 7:07 p.m.
report
metasource: Fairsharing.orgversion: FAIRsharing.org: COVID-HEP Registry; COVID-HEP Registry; DOI: https://doi.org/10.25504/FAIRsharing.bsAeqi; Last edited: May 20, 2021, 1:41 p.m.; Last accessed: Jan 03 2022 7:07 p.m.
metasource: Fairsharing.org
version: FAIRsharing.org: COVID-HEP Registry; COVID-HEP Registry; DOI: https://doi.org/10.25504/FAIRsharing.bsAeqi; Last edited: May 20, 2021, 1:41 p.m.; Last accessed: Jan 03 2022 7:07 p.m.
liver disease patient care report
Need help integrating and/or managing biomedical data?